(Total Views: 207)
Posted On: 09/04/2019 4:30:58 PM
Post# of 74551

$TNXP News Article - Tonix Pharmaceuticals Doses Participants in Phase 1 Study Evaluating TNX-601 for the Daytime Treatment of Posttraumatic Stress Disorder https://marketwirenews.com/news-releases/toni...50512.html


My Twitter: WhyteStocks